BIOTECanada - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
BIOTECanada

BIOTECanada

Publication
0 followers

The national industry association for Canadian biotechnology. Provides news and resources on Canada’s biotech sector, representing 250+ member companies and institutions.

Recent Posts

Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. – Announce the Successful Delivery of a Seasonal Influenza Vaccine in...
News•Feb 10, 2026

Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. – Announce the Successful Delivery of a Seasonal Influenza Vaccine in...

Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) announced they have completed formulation, aseptic fill‑finish, and clinical packaging for Aramis’s seasonal influenza vaccine. The milestone delivers clinical‑grade material for Phase 1/2 trials, meeting regulatory quality and safety requirements. The achievement underscores BMC’s capacity to support Canadian biotech firms with integrated manufacturing services. It positions Aramis’s plant‑based vaccine platform for further development and potential market entry.

By BIOTECanada
Aspect Biosystems and Novo Nordisk – Enter New Phase of Partnership to Develop Curative Medicines for Diabetes
News•Jan 20, 2026

Aspect Biosystems and Novo Nordisk – Enter New Phase of Partnership to Develop Curative Medicines for Diabetes

Novo Nordisk and Aspect Biosystems have entered a new partnership phase to develop curative cellular medicines for diabetes. Aspect will acquire Novo Nordisk's stem‑cell‑derived islet and hypoimmune technologies and lead development, manufacturing, and commercialization, while Novo Nordisk retains rights to...

By BIOTECanada
VIDO – Five Ways Our Research Strengthened Animal Health in 2025
News•Dec 16, 2025

VIDO – Five Ways Our Research Strengthened Animal Health in 2025

In 2025 the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) tackled five critical animal‑health challenges, from a first‑record H5N1 outbreak in dairy cattle to a world‑first chlamydia vaccine for endangered koalas. Researchers demonstrated natural immunity in infected cows,...

By BIOTECanada